13F HOLDINGS REPORT
GSK plc
Quarter ended Q4 2025 · Filed February 12, 2026 · Accession 0001999371-26-003198
Total Value
$799.0M
Positions
15
Other Managers
0
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 18,245,691 | $310.2M | 38.82% |
| 2 | CRISPR THERAPEUTICS AG | CRSP | 3,220,627 | $168.9M | 21.14% |
| 3 | BIONTECH SE | BNTX | 889,824 | $84.7M | 10.60% |
| 4 | VIR BIOTECHNOLOGY INC | VIR | 8,550,954 | $51.6M | 6.45% |
| 5 | LYELL IMMUNOPHARMA INC | LYEL | 1,512,659 | $46.6M | 5.83% |
| 6 | IDEAYA BIOSCIENCES INC | IDYA | 1,333,333 | $46.1M | 5.77% |
| 7 | CYTOKINETICS INC | CYTK | 340,434 | $21.6M | 2.71% |
| 8 | SPERO THERAPEUTICS INC | SPRO | 9,190,606 | $21.4M | 2.68% |
| 9 | FULCRUM THERAPEUTICS INC | FULC | 1,785,714 | $20.2M | 2.53% |
| 10 | BICYCLE THERAPEUTICS PLC | BCYC | 1,529,561 | $10.8M | 1.36% |
| 11 | CVRX INC | CVRX | 1,007,583 | $7.2M | 0.90% |
| 12 | NKARTA INC | NKTX | 3,150,732 | $5.8M | 0.73% |
| 13 | REGENXBIO INC | RGNX | 271,456 | $3.9M | 0.49% |
| 14 | SENSEONICS HLDGS INC | SENS | 10,856 | $59,925 | 0.01% |
| 15 | HARVARD BIOSCIENCE INC | HBIO | 11,151 | $7,458 | 0.00% |